Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)

Creative Commons License

Drake M. J., Chapple C., Esen A. A., Athanasiou S., Cambronero J., Mitcheson D., ...More

EUROPEAN UROLOGY, vol.70, no.1, pp.136-145, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 70 Issue: 1
  • Publication Date: 2016
  • Doi Number: 10.1016/j.eururo.2016.02.030
  • Journal Name: EUROPEAN UROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.136-145
  • Keywords: Add-on therapy, Incontinence, Mirabegron, Overactive bladder, Solifenacin, QUALITY-OF-LIFE, URINARY-INCONTINENCE, NERVE-STIMULATION, IMPACT, ONABOTULINUMTOXINA, PERCEPTION, AGONIST, BURDEN
  • Dokuz Eylül University Affiliated: Yes


Background: Incontinence has a greater detrimental effect on quality of life than other symptoms of overactive bladder (OAB) and is often difficult to treat with antimuscarinic monotherapy.